TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT01794377

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 30 minutes of high intensity training
Description: This group will carry out a 5-min warm-up period on bicycle ergometer at an intensity corresponding to 50% of Vo2max before performed eight times the intermittent training exercise as follows:~* 30 sec at 120% of Vo2max,~* 1 min at 50% of Vo2max,~* 15 sec at 30-40 revolutions per minute of strength training at 100% of the maximal anaerobic power, which will be first determined by means of a force-velocity test on a Monark ergometer,~* 1 min at 50% of Vo2max.~The training session will be terminated by a 3-min cool-down period at 40% of Vo2max.~Training three times per week for 5 months under supervision of an exercise physiologist.~Initial nutritional education session at the beginning of the study Questionnaires on training experience during the 5 months training period (Exercise difficulties, pain...).~Dietary Supplement: supplementation in fruits and vegetables (5 per day) during all the study.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: 40 of an endurance training
Description: The moderate-intensity continuous exercise group will carry out a 40-min session of continuous cycling at a moderate intensity (50 % of Vo2max).~Training three times per week for 5 months under supervision of an exercise physiologist.~Initial nutritional education session at the beginning of the study Questionnaires on training experience during the 5 months training period (Exercise difficulties, pain...).~Dietary Supplement: supplementation in fruits and vegetables (5 per day) during all the study.
Study: NCT04483843

Intervention type: OTHER
Intervention: No intervention
Description: No intervention will be performed while it is retrospective observational study.
Study: NCT02327039

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Description: Sodium glucose cotransporter-2 inhibitor

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Tables of Dapagliflozin placebo
Study: NCT02715401

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HIP1402
Study: NCT03848338

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Electrocochleography
Description: Electrocochleography measurement Intra-operatively and Post-operatively at follow-up appointments along with correlative measurements (Impedance, eCAP, PTA, Speech)
Study: NCT01696721

Intervention type: OTHER
Intervention: No intervention
Study: NCT02955862

Intervention type: OTHER
Group type: OTHER
Intervention: Vietnam Cryptococcal Retention in Care Study (CRICS)
Description: Drug: Fluconazole HIV-infected patients with CD4 ≤100 cells/μL who present for HIV care at outpatient clinics (OPCs) in Vietnam where CrAg screening is offered will be recruited into the study. Study participants will be screened for cryptococcal antigen using the Lateral Flow Assay (LFA). Those who are CrAg-positive, but have no features of central nervous system (CNS) disease, will be treated with high-dose fluconazole.~Other Names:~• Fluconazole
Study: NCT02760576

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BAY 987521
Description: Each 50 cm\*2 test site area of a subject requires 100 mg of a test material to obtain a standard 2 mg/cm\*2 test application.
Study: NCT02419521

Intervention type: DEVICE
Group type: OTHER
Intervention: Resolute Onyx Stent - 2.25 mm - 4.0 mm
Study: NCT04123002

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Miswak chewing sticks
Description: Chewing stick are routinely used by this population
Study: NCT02922972

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Autologous Platelet Rich Plasma obtained with RegenKit®-BCT
Description: After complete resection of the keloid scar, the first injection was administered before closure into the lesion resection bed and edges. Three additional injections were administered with a one-month interval.
Study: NCT04637490

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: patellar component
Description: patellar resurfacing
Study: NCT02748473

Intervention type: OTHER
Group type: OTHER
Intervention: Pilates Exercises program
Description: The volunteers were divided in two groups:~Group I: Pilates exercise program involving only the Pilates exercises protocol Group II: Pilates exercises program with voluntary pelvic floor muscle contraction.~The protocol of both groups consisted of 24 bi-weekly 1-h individual sessions of Pilates exercises program.~Both groups performed the same protocol . For the group PEP + PFMC the instructor asked for the maximum contraction muscle of the pelvic floor muscle, during expirations with 5 repetitions performed alternately, thus avoiding pelvic floor muscle exhaustion.~After the 24 sessions, both groups were retested with the same measured methods of the baseline.

Intervention type: OTHER
Group type: OTHER
Intervention: Pilates Exercises program
Description: The volunteers were divided in two groups:~Group I: Pilates exercise program involving only the Pilates exercises protocol Group II: Pilates exercises program with voluntary pelvic floor muscle contraction.~The protocol of both groups consisted of 24 bi-weekly 1-h individual sessions of Pilates exercises program.~Both groups performed the same protocol . For the group PEP + PFMC the instructor asked for the maximum contraction muscle of the pelvic floor muscle, during expirations with 5 repetitions performed alternately, thus avoiding pelvic floor muscle exhaustion.~After the 24 sessions, both groups were retested with the same measured methods of the baseline.

Intervention type: OTHER
Group type: OTHER
Intervention: Pelvic floor muscle strength
Description: evaluated the pelvic floor strength by oxford scale and vaginal pressure before and after the 12 sessions with Pilates Exercises Program on sedentary nulliparous women

Intervention type: OTHER
Group type: OTHER
Intervention: 3D perineal ultrasound
Description: evaluated the pubovisceral muscle thickness and levator hiatus area by 3D perineal ultrasound before and after the 12 sessions with Pilates Exercises Program on sedentary nulliparous women
Study: NCT00812539

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Subject/Provider Portal Diabetes Connected Health tool - Deluxe
Description: Subjects enrolled into the Deluxeintervention will use a glucometer, a modem to upload the blood glucose readings to a secure, web-based portal (Diabetes Connected Health tool) where they can view detailed graphical representation of their blood glucose levels over time, educational material regarding diabetes management and receive personalized tips and feedback from their physicians (who will also have access to their subjects' information on the web portal and contact them by an embedded messaging system). Subjects with new high or low readings will be flagged. Providers can initiate messages to subjects regarding symptoms or medications. A medication summary and log of all readings uploaded with date/time will be displayed on the website as well as a graphical display of all uploaded glucose readings over time and will allow subjects to enter comments regarding each critical reading.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Subject only Portal Diabetes Connected Health Tool Basic
Description: Patients enrolled in the Diabetes Connect Basic intervention will use a glucometer, a modem which will upload the blood glucose readings to a secure, web-based portal (the Diabetes Connected Health tool) where they can view their readings in a less detailed/journal fashion. No detailed graphical representation of their blood glucose levels over time is available to this group, nor is any educational material regarding diabetes management. Their physicians will not have access to these subjects' information on the web portal and will not have the ability to contact them by an embedded messaging system.
Study: NCT02748473

Intervention type: OTHER
Group type: OTHER
Intervention: 3D perineal ultrasound
Description: evaluated the pubovisceral muscle thickness and levator hiatus area by 3D perineal ultrasound before and after the 12 sessions with Pilates Exercises Program on sedentary nulliparous women
Study: NCT02248142

Intervention type: DRUG
Intervention: Pramipexole
Study: NCT03956199

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: pulpotomy
Description: removal of the pulp from pulp chamber

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Root canal treatment
Description: Removal of at the entire content of the root canal system and root canal obturation
Study: NCT03277157

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: B. lactis B94
Description: A probiotic dose of 15 billion per capsule.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo capsule
Study: NCT04603716

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Eccentric Muscle Energy Technique
Description: Conventional Treatment given to both groups (Hot pack for 15 minutes, Mobilization, AROM Exercises 10 sets x 3days in a week)~Reciprocal inhibition of target muscle (i.e. levator scapulae ,pectoralis major, upper trapezius) causing relaxation, patient force is minimal towards maximal therapist force, 5-7 repetition for 2-4seconds 3 days in a week up to 6 weeks.~Muscle is taken from shortened to lengthened position.
Study: NCT03084861

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cord Blood Eye Drops
Description: Eye drops plasma from cord blood diluted v/v with Plasmalyte®, without antimicrobial preservatives

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Conventional treatment
Description: 1. Artificial tears: Lubristil ®~2. Therapeutic Contact lens: Air Optix Night\&Day
Study: NCT00587132

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Synthetic Human Secretin
Description: 0.2mcg/kg one time dose.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Synthetic Human Secretin
Description: 0.2mcg/kg one time dose.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Synthetic Human Secretin
Description: 0.2mcg/kg one time dose.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Synthetic Human Secretin
Description: 0.2mcg/kg one time dose.
Study: NCT03038256

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: concurrent capecitabine-based long-term radiotherapy followed by 4 cycles XELOX and a delayed TME
Description: concurrent capecitabine-based long-term radiotherapy: capecitabine 825mg/m2,bid,d1-5, q week with Radiation treatment. Radiation treatment was given at 1·8 Gy per day, 5 days per week for 5-6 weeks, after a 45 Gy radiation dose in 25 fractions to the pelvis, a boost dose of 5·4 Gy in 3 fractions to the tumor bed or concurrent boosted.~XELOX:~Oxaliplatin: 130mg/m2,IV,d1; Capecitabine: 1000mg/m2,bid,d1-14; repeated every 3 weeks~Surgery Procedure:~Total Mesorectal Excision

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: concurrent capecitabine-based long-term radiotherapy followed by a Regular TME and 6 Cycles XELOX
Description: concurrent capecitabine-based long-term radiotherapy: capecitabine 825mg/m2,bid,d1-5, q week with Radiation treatment. Radiation treatment was given at 1·8 Gy per day, 5 days per week for 5-6 weeks, after a 45 Gy radiation dose in 25 fractions to the pelvis, a boost dose of 5·4 Gy in 3 fractions to the tumor bed or concurrent boosted.~XELOX:~Oxaliplatin: 130mg/m2,IV,d1; Capecitabine: 1000mg/m2,bid,d1-14; repeated every 3 weeks~Surgery Procedure:~Total Mesorectal Excision
Study: NCT01339702

Intervention type: OTHER
Intervention: The National Prehospital TBI Management Guidelines
Description: In the post-implementation (after) cohort, implementation of the entire bundle of the TBI treatment guidelines with special emphasis on prevention and treatment of hypotension (IV crystalloids), prevention and treatment of hypoxia (pre-oxygenation with high-flow O2 via non-rebreather mask, bag-valve-mask, extraglottic airways/intubation when basic maneuvers have failed), and prevention of hyperventilation (in intubated patients) and prevention/treatment of hypoventilation (in all patients).
Study: NCT03018145

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Wagon

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Standard stretcher car
Study: NCT01380119

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: V7
Description: experimental arm

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: placebo pill
Study: NCT01878890

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efavirenz 600mg
Description: Efavirenz 600 mg (oral daily intake)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efavirenz 1200 mg
Description: Efavirenz 1200mg (oral daily intake)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efavirenz 1800 mg
Description: Efavirenz 1800mg (oral daily intake)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efavirenz 2200 mg
Description: Efavirenz 2200mg (oral daily intake)
Study: NCT03431779

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Adipose derived stem cell transplantation via lipofilling
Description: Liposuction of 60cc abdominal fat with its adipose derived stem cells which will be reinjected (10-20 cc) in the vestibular area after centrifugation for 3 minutes at 1000 rpm and decantation of oil and red blood cells.
Study: NCT04603716

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Concentric muscle energy technique
Description: Group B: Concentric Muscle Energy Technique: (Autogenic inhibition of target muscle (i.e. levator scapulae ,pectoralis major, upper trapezius) patient force is greater than therapist force, 5-7repitition for 3-4seconds)Muscle is taken from lengthened to shortened position.~On eligible participants baseline assessment was done,3 session were given 3days per week, post intervention assessment was taken at 1st 3rd and 6th week
Study: NCT04549961

Intervention type: OTHER
Intervention: Nutrition
Description: type and amount of food eaten or type and amount of oral nutritional supplements as well as enteral or parenteral nutrition
Study: NCT03431779

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Surgical excision
Description: Excision of painful areas
Study: NCT02952261

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: template-guided localization
Description: Based on CT data, digital model of the navigational template was created using CAD software and imported to 3D printer. The navigational template serves as a guider to the localizer in lung nodule localization.

Intervention type: OTHER
Group type: OTHER
Intervention: CT-guided localization
Description: Percutaneous lung nodule localization was conducted under the real-time guidance of CT scan. This is the conventional method of transthoracic lung nodule localization.
Study: NCT00310362

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Use of Interactive Voice Response (IVR) system to improve adherence to GI appointments and prep procedures
Description: Interactive voice response system (IVR) calls patients 7 or 3 days prior to their appointment. Information available in the IVR system is based on the same template nurses use in usual care and includes an appointment reminder, preparation instructions, basic information about the procedure, and answers to commonly asked questions.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Use of Interactive Voice Response (IVR) system to improve adherence to GI appointments and prep procedures
Description: Interactive voice response system (IVR) calls patients 7 or 3 days prior to their appointment. Information available in the IVR system is based on the same template nurses use in usual care and includes an appointment reminder, preparation instructions, basic information about the procedure, and answers to commonly asked questions.
Study: NCT02772055

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Moxibustion
Description: Moxibustion at three acupuncture point(EX-LE04,ST35,ST36).12 sessions of moxibustion treatment over a period of 4 weeks, 3 sessions per week.Each session will last 30 minutes.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Moxibustion
Description: Moxibustion at three acupuncture point(EX-LE04,ST35,ST36).12 sessions of moxibustion treatment over a period of 4 weeks, 3 sessions per week.Each session will last 30 minutes.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Moxa smoke purification device
Description: Investigators place a purification device(Shenzhen Conyson Electronic Technology Co, Ltd,C200 moxa smoke purification device,Shenzhen,China) at the top of the moxibustion to remove the moxa smoke.
Study: NCT02890095

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Breast cancer surgery
Description: First, 2 specific adipose tissue samples will be performed during the surgery :~* 1 sample near the tumor, to measure the contaminants (dioxins, PCBs, organochlorine pesticides, polybrominated compounds)~* 1 remote sample of the tumor bed, superficial, at least 5 cm from the tumor, to be used to determine the level of expression of hormone receptors and to establish the expression profiles, after cutting and inclusion in paraffin blocks for marking IHC.~These withdrawals are made during surgery, during surgery, as part of the intervention and the remodeling of the mammary gland (standard care for patients). This is unused balance for diagnostic.~Before anaesthesia : specific blood samples (for the determination of circulating pollutants and for the analysis of gene polymorphism)

Intervention type: PROCEDURE
Group type: OTHER
Intervention: plastic surgery
Description: The excision piece will follow the classical pathological circuit.~A specific charge of subcutaneous adipose tissue will be performed as part of research on the surgical specimen. This sample will be used:~* measuring contaminants (dioxins, PCBs, organochlorine pesticides, polybrominated compounds)~* to determine the level of expression of hormone receptors and to establish the expression profiles, after cutting and inclusion in paraffin blocks for marking IHC. These samples are all made during surgery, for usual care surgery these patients.~Before anaesthesia : specific blood samples (for the determination of circulating pollutants and for the analysis of gene polymorphism)
Study: NCT00310362

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Use of Interactive Voice Response (IVR) system to improve adherence to GI appointments and prep procedures
Description: Interactive voice response system (IVR) calls patients 7 or 3 days prior to their appointment. Information available in the IVR system is based on the same template nurses use in usual care and includes an appointment reminder, preparation instructions, basic information about the procedure, and answers to commonly asked questions.
Study: NCT04616482

Intervention type: BEHAVIORAL
Intervention: Digital therapeutic carbohydrate restriction (TCR) program
Description: A 12-week, personalized, online program to teach and coach patients about therapeutic carbohydrate restriction as for obesity and/or T2D (or risk of T2D). The program is intended to enhance the usual clinical care provided for patients.
Study: NCT04015986

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Microbiota Directed Complementary Food-2
Description: MDCF prototype with four complimentary food ingredients without powdered milk (rationale: lead with evidence from the recently completed pre-POC clinical trial of promoting growth promoting microbiota and positive effects on growth

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Ready to Use Supplementary Food
Description: Rice-lentil based RUSF (rationale: reference standard of care for post-SAM, MAM; based on knowledge of its effects on child growth and the gut microbiota)
Study: NCT01619254

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Hand washing with soap and hand finger nail clipping
Description: Assess the impact of hand washing with soap and nail clipping on child health

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Hand washing with soap and hand finger nail clipping
Description: Assess the impact of hand washing with soap and nail clipping on child health

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Hand washing with soap and hand finger nail clipping
Description: Assess the impact of hand washing with soap and nail clipping on child health

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Hand washing with soap and hand finger nail clipping
Description: Assess the impact of hand washing with soap and nail clipping on child health
Study: NCT03605329

Intervention type: OTHER
Group type: OTHER
Intervention: to explore the severity of NAC in case of OSAS
Description: After overnight polysomnography, cardiovascular autonomic neuropathy will be evaluated by different methods: study of HRV, cardiovascular autonomic reflex test (Ewing), measurements of urinary levels of catecholamines and measurements of sweat gland dysfunction using Sudoscan.~The severity of CAN will be evaluated in T1D patients with moderate to severe OSAS (apnea hypopnea index (IAH) ≥15 / hour) compared to T1D patients with IAH \<15 / hour.
Study: NCT03680014

Intervention type: DIAGNOSTIC_TEST
Intervention: CUSH
Description: Machine learning assisted remote monitoring/ telehealth platform to predict and prevent falls

Intervention type: DIAGNOSTIC_TEST
Intervention: CUSH
Description: Machine learning assisted remote monitoring/ telehealth platform to predict and prevent falls

Intervention type: DIAGNOSTIC_TEST
Intervention: CUSH
Description: Machine learning assisted remote monitoring/ telehealth platform to predict and prevent falls

Intervention type: DIAGNOSTIC_TEST
Intervention: CUSH
Description: Machine learning assisted remote monitoring/ telehealth platform to predict and prevent falls

Intervention type: DIAGNOSTIC_TEST
Intervention: CUSH
Description: Machine learning assisted remote monitoring/ telehealth platform to predict and prevent falls

Intervention type: DIAGNOSTIC_TEST
Intervention: CUSH
Description: Machine learning assisted remote monitoring/ telehealth platform to predict and prevent falls
Study: NCT02929108

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Facebook
Description: Participants will be enrolled in a Secret Facebook group for social support and education

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Facebook
Description: Participants will be enrolled in a Secret Facebook group for social support and education

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ACCESS
Description: Intervention will have two components.~1. Participants will be enrolled in a Secret Facebook group for social support and education~2. Participants will use web conferencing technology to participate in their interdisciplinary team meeting
Study: NCT03742713

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CPC634 (CriPec® docetaxel)
Description: Docetaxel containing CriPec® nanoparticles